ABCL – abcellera biologics inc. - common shares (US:NASDAQ)
Stock Stats
News
Earnings Release: Here's Why Analysts Cut Their AbCellera Biologics Inc. (NASDAQ:ABCL) Price Target To US$12.71 [Yahoo! Finance]
AbCellera Biologics Inc. (NASDAQ: ABCL) had its price target lowered by analysts at KeyCorp from $8.00 to $7.00. They now have an "overweight" rating on the stock.
AbCellera Biologics Inc. (NASDAQ:ABCL) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]
Form 10-Q AbCellera Biologics Inc. For: Mar 31
Form 8-K AbCellera Biologics Inc. For: May 07
Form ARS AbCellera Biologics Inc. For: Dec 31
Form DEFA14A AbCellera Biologics Inc.
Form DEF 14A AbCellera Biologics Inc. For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.